These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 36418517)
1. The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development. Aljohani AI; Toss MS; Green AR; Rakha EA Breast Cancer Res Treat; 2023 Apr; 198(3):423-435. PubMed ID: 36418517 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of Cyclin B2 ( Aljohani AI; Toss MS; El-Sharawy KA; Mirza S; Ball GR; Green AR; Rakha EA Am J Cancer Res; 2022; 12(2):469-489. PubMed ID: 35261781 [TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer. Aljohani AI; Toss MS; Kurozumi S; Joseph C; Aleskandarany MA; Miligy IM; Ansari RE; Mongan NP; Ellis IO; Green AR; Rakha EA Breast Cancer Res Treat; 2020 Jan; 179(1):79-90. PubMed ID: 31599393 [TBL] [Abstract][Full Text] [Related]
4. The expression of high mobility group protein 3 ( Aljohani AI; Alsaeed SA; Toss MS; Raafat SA; Green AR; Rakha EA Am J Cancer Res; 2023; 13(11):5334-5351. PubMed ID: 38058796 [TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer. Kariri YA; Alsaleem M; Joseph C; Alsaeed S; Aljohani A; Shiino S; Mohammed OJ; Toss MS; Green AR; Rakha EA Breast Cancer Res Treat; 2021 Jan; 185(2):293-305. PubMed ID: 33073304 [TBL] [Abstract][Full Text] [Related]
6. Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer. Aleskandarany MA; Sonbul S; Surridge R; Mukherjee A; Caldas C; Diez-Rodriguez M; Ashankyty I; Albrahim KI; Elmouna AM; Aneja R; Martin SG; Ellis IO; Green AR; Rakha EA Br J Cancer; 2017 Oct; 117(8):1176-1184. PubMed ID: 28829761 [TBL] [Abstract][Full Text] [Related]
7. A key genomic subtype associated with lymphovascular invasion in invasive breast cancer. Kurozumi S; Joseph C; Sonbul S; Alsaeed S; Kariri Y; Aljohani A; Raafat S; Alsaleem M; Ogden A; Johnston SJ; Aleskandarany MA; Fujii T; Shirabe K; Caldas C; Ashankyty I; Dalton L; Ellis IO; Desmedt C; Green AR; Mongan NP; Rakha EA Br J Cancer; 2019 Jun; 120(12):1129-1136. PubMed ID: 31114020 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer. Joseph C; Arshad M; Kurozomi S; Althobiti M; Miligy IM; Al-Izzi S; Toss MS; Goh FQ; Johnston SJ; Martin SG; Ellis IO; Mongan NP; Green AR; Rakha EA Breast Cancer Res Treat; 2019 Apr; 174(2):387-399. PubMed ID: 30554343 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer. Kariri YA; Joseph C; Kurozumi S; Toss MS; Alsaleem M; Raafat S; Mongan NP; Aleskandarany MA; Green AR; Rakha EA Breast Cancer Res Treat; 2020 Jan; 179(2):349-357. PubMed ID: 31679074 [TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer. Aleskandarany MA; Sonbul SN; Mukherjee A; Rakha EA Pathobiology; 2015 Sep; 82(3-4):113-23. PubMed ID: 26330352 [TBL] [Abstract][Full Text] [Related]
11. Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis. Kurozumi S; Joseph C; Sonbul S; Gorringe KL; Pigera M; Aleskandarany MA; Diez-Rodriguez M; Nolan CC; Fujii T; Shirabe K; Kuwano H; Storr S; Martin SG; Ellis IO; Green AR; Rakha EA Breast Cancer Res Treat; 2018 Aug; 170(3):525-533. PubMed ID: 29633055 [TBL] [Abstract][Full Text] [Related]
12. Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer. Aljohani AI; Joseph C; Kurozumi S; Mohammed OJ; Miligy IM; Green AR; Rakha EA Breast Cancer Res Treat; 2020 Jun; 181(3):541-551. PubMed ID: 32350677 [TBL] [Abstract][Full Text] [Related]
13. Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival. Joseph C; Alsaleem M; Orah N; Narasimha PL; Miligy IM; Kurozumi S; Ellis IO; Mongan NP; Green AR; Rakha EA Breast Cancer Res Treat; 2020 Jul; 182(2):267-282. PubMed ID: 32445177 [TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma. Hamy AS; Lam GT; Laas E; Darrigues L; Balezeau T; Guerin J; Livartowski A; Sadacca B; Pierga JY; Vincent-Salomon A; Coussy F; Becette V; Bonsang-Kitzis H; Rouzier R; Feron JG; Benchimol G; Laé M; Reyal F Breast Cancer Res Treat; 2018 Jun; 169(2):295-304. PubMed ID: 29374852 [TBL] [Abstract][Full Text] [Related]
15. Expression of KIF2A, NDC80, CDK1, and CCNB1 in breast cancer patients: Their interaction and linkage with tumor features and prognosis. Wang C; Xie X; Li W; Jiang D J Clin Lab Anal; 2022 Sep; 36(9):e24647. PubMed ID: 35949045 [TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer. Kariri Y; Toss MS; Alsaleem M; Elsharawy KA; Joseph C; Mongan NP; Green AR; Rakha EA Breast Cancer Res Treat; 2022 Apr; 192(3):529-539. PubMed ID: 35124721 [TBL] [Abstract][Full Text] [Related]
17. Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion. Sonbul SN; Aleskandarany MA; Kurozumi S; Joseph C; Toss MS; Diez-Rodriguez M; Nolan CC; Mukherjee A; Martin S; Caldas C; Ellis IO; Green AR; Rakha EA Mod Pathol; 2018 Nov; 31(11):1675-1682. PubMed ID: 29955149 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of heat shock protein 90AA1 (HSP90α) in invasive breast cancer. Alsaeed SA; Toss M; Alsaleem M; Aleskandarany M; Joseph C; Kurozumi S; Ball G; Mongan N; Green A; Rakha E J Clin Pathol; 2022 Apr; 75(4):263-269. PubMed ID: 33766957 [TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Rakha EA; Martin S; Lee AH; Morgan D; Pharoah PD; Hodi Z; Macmillan D; Ellis IO Cancer; 2012 Aug; 118(15):3670-80. PubMed ID: 22180017 [TBL] [Abstract][Full Text] [Related]